1. Home
  2. SRPT vs JSPRW Comparison

SRPT vs JSPRW Comparison

Compare SRPT & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • JSPRW
  • Stock Information
  • Founded
  • SRPT 1980
  • JSPRW N/A
  • Country
  • SRPT United States
  • JSPRW United States
  • Employees
  • SRPT N/A
  • JSPRW 45
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • Sector
  • SRPT Health Care
  • JSPRW Health Care
  • Exchange
  • SRPT Nasdaq
  • JSPRW Nasdaq
  • Market Cap
  • SRPT N/A
  • JSPRW N/A
  • IPO Year
  • SRPT 1997
  • JSPRW 2020
  • Fundamental
  • Price
  • SRPT $113.19
  • JSPRW $0.16
  • Analyst Decision
  • SRPT Buy
  • JSPRW
  • Analyst Count
  • SRPT 22
  • JSPRW 0
  • Target Price
  • SRPT $174.64
  • JSPRW N/A
  • AVG Volume (30 Days)
  • SRPT 891.1K
  • JSPRW N/A
  • Earning Date
  • SRPT 02-26-2025
  • JSPRW N/A
  • Dividend Yield
  • SRPT N/A
  • JSPRW N/A
  • EPS Growth
  • SRPT N/A
  • JSPRW N/A
  • EPS
  • SRPT 1.22
  • JSPRW N/A
  • Revenue
  • SRPT $1,640,348,000.00
  • JSPRW N/A
  • Revenue This Year
  • SRPT $52.33
  • JSPRW N/A
  • Revenue Next Year
  • SRPT $69.75
  • JSPRW N/A
  • P/E Ratio
  • SRPT $91.67
  • JSPRW N/A
  • Revenue Growth
  • SRPT 48.45
  • JSPRW N/A
  • 52 Week Low
  • SRPT $102.16
  • JSPRW N/A
  • 52 Week High
  • SRPT $173.25
  • JSPRW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 39.04
  • JSPRW N/A
  • Support Level
  • SRPT $111.48
  • JSPRW N/A
  • Resistance Level
  • SRPT $120.05
  • JSPRW N/A
  • Average True Range (ATR)
  • SRPT 3.52
  • JSPRW 0.00
  • MACD
  • SRPT -0.26
  • JSPRW 0.00
  • Stochastic Oscillator
  • SRPT 6.59
  • JSPRW 0.00

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: